IL6 and Insulin resistance: Two studies showed that insulin resistance and type 2 diabetes are associated with higher levels of C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-α (TNF- α), which are markers of subclinical systemic inflammation [37,38].